Systemic evaluation of the molecular mechanism in metastatic esophageal cancer and high risk group profiling
博士 === 長庚大學 === 臨床醫學研究所 === 99 === Carcinoma of the esophagus is a highly malignant cancer and generally carries a poor prognosis. Five year survival is less than 25% even after complete surgical removal. In order to improve resectability and reduce distant metastases, the combination of chemothe...
Main Authors: | Chao Yin Kai, 趙盈凱 |
---|---|
Other Authors: | A. J. Cheng |
Format: | Others |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/71797726475022169047 |
Similar Items
-
Molecular changes in pre-metastatic lymph nodes of esophageal cancer patients.
by: Benjamin Otto, et al.
Published: (2014-01-01) -
Metastatic squamous cell carcinoma of colon from esophageal cancer
by: Natasha Garg, et al.
Published: (2017-04-01) -
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
by: Ting Xu, et al.
Published: (2020-10-01) -
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
by: Atkins, K., et al.
Published: (2022) -
Allele Frequency of ABO Blood Group Antigen and the Risk of Esophageal Cancer
by: Narender Kumar, et al.
Published: (2014-01-01)